Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
NKGen Biotech Inca clinicalstage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer NK cell therapeutics and HekaBio KK headquartered in Chuoku Tokyo HekaBio announced a strat...
Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation Blueprint adding to its portfolio a commercialized medicine a promising pipeline and the expertise of a company specializing in systemic mastocytosis
GC Biopharma KS a South Korean pharmaceutical company announced that its varicella vaccine BARYCELA has received marketing authorization from the Drug Administration of Vietnam DAV
SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure today announced that the company and its codevelopment partner
th Computer Software Assurance a virtual gathering planned on August st and nd is a strategic deep dive into the future of validation
The theme of the award ceremony Pharma Manufacturing and Automation Excellence is based on the FUTURE READINESS strategic AUTOMATION SUSTAINABILITY practices and effort to upskill selves and the workforce
The th Annual Pharma Manufacturing and Automation Convention will take place on October th and th at Hotel Novotel HICC Hyderabad uniting industry pioneers manufacturing leaders
WEHI has formed a partnership with the Parkinsons Research Foundation with one clear goal to intensify the search for drug treatments to stop Parkinsons
Partners Group one of the largest firms in the global private markets industry has agreed to exit its longstanding holding in PCI Pharma Services PCI or the Company a global contract manufacturing and development organization
SandboxAQ and iOncologi today announced a strategic collaboration to jointly develop validate and commercialize a novel highfidelity mRNA vaccine for glioblastoma the most common and aggressive malignant brain tumor in adults
